# National Institute of Cardiology, Warsaw, Poland

Organization · id `cardio:org-national-institute-of-cardiology-warsaw-poland` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=National+Institute+of+Cardiology%2C+Warsaw%2C+Poland>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 10 trials in this atlas.

## Technical summary

Sponsor class other. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: National Institute of Cardiology, Warsaw, Poland
- Sponsor class: OTHER

## Connected pages

- Sponsors: Optimizing Diagnostics Of Syncope Events Using Intelligent Telemetric Solutions. (`cardio:ct-nct01265290`)
- Sponsors: Telemetric Arrhythmia and Syncope Diagnosis - Evaluation of Arrhythmia Treatment Efficacy (`cardio:ct-nct01265303`)
- Sponsors: Telemetric Arrhythmia Diagnosis in Adults (`cardio:ct-nct01265758`)
- Sponsors: Optimizing Diagnostics Of Arrhythmia Events In Children Using Intelligent Telemetric Solutions (`cardio:ct-nct01265771`)
- Sponsors: Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure (`cardio:ct-nct03445949`)
- Sponsors: Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI (`cardio:ct-nct04695106`)
- Sponsors: Empagliflozin in Hypertrophic Cardiomyopathy (`cardio:ct-nct05182658`)
- Sponsors: Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions (`cardio:ct-nct05305612`)
- Sponsors: Optimal Medical Treatment of Difficult-to-treat Hypertension (`cardio:ct-nct06275763`)
- Sponsors: Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes (`cardio:ct-nct07254572`)

## Provenance

Content hash: d727525fcc8be9b2776a20fa2477b9e60feafb936f9a3218b768c927da4894ad
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
